Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Cubberley R. B. Hypertension: a view from Detroit. J Natl Med Assoc. 1987 Mar;79 (Suppl):23–26. [PMC free article] [PubMed] [Google Scholar]
- Flamenbaum W., Weber M. A., McMahon F. G., Materson B. J., Carr A. A., Poland M. Monotherapy with labetalol compared with propranolol. Differential effects by race. J Clin Hypertens. 1985 Mar;1(1):56–69. [PubMed] [Google Scholar]
- Oster G., Huse D. M., Delea T. E., Savage D. D., Colditz G. A. Cost effectiveness of labetalol and propranolol in the treatment of hypertension among blacks. J Natl Med Assoc. 1987 Oct;79(10):1049–1055. [PMC free article] [PubMed] [Google Scholar]
- Rostand S. G., Kirk K. A., Rutsky E. A., Pate B. A. Racial differences in the incidence of treatment for end-stage renal disease. N Engl J Med. 1982 May 27;306(21):1276–1279. doi: 10.1056/NEJM198205273062106. [DOI] [PubMed] [Google Scholar]
- Wallin J. D. Refractory hypertension: patient types, special problems, and approaches to therapy. J Natl Med Assoc. 1987 Mar;79 (Suppl):9–12. [PMC free article] [PubMed] [Google Scholar]
- Wright J. T., Jr Risk factors in the management of the unique hypertensive patient. J Natl Med Assoc. 1987 Mar;79 (Suppl):17–22. [PMC free article] [PubMed] [Google Scholar]